Skip to main content

Advertisement

SpringerLink
Log in

Lyme neuroborreliosis in a patient treated with TNF-alpha inhibitor

  • Case Report
  • Published:
Infection Aims and scope Submit manuscript

Abstract

A 57-year-old woman, receiving TNF-alpha inhibitor adalimumab for psoriasis, presented with early Lyme neuroborreliosis (Bannwarth’s syndrome). Discontinuation of adalimumab and 14-day therapy with ceftriaxone resulted in a smooth course and favorable outcome of Lyme borreliosis. This is the first report on Lyme neuroborreliosis in a patient treated with TNF-alpha inhibitor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379:461–73.

    Article  PubMed  Google Scholar 

  2. Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Kristoferitsch W, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect. 2011;7:69–79.

    Article  Google Scholar 

  3. Wallis D. Infection risk and biologics: current update. Curr Opin Reumatol. 2014;26:404–9.

    Article  CAS  Google Scholar 

  4. Singh JA, Wells GA, Christensen R, Tanjong Ghogomu E, Maxwell L, Macdonald JK, et al. Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev. 2011. doi:10.1002/14651858.CD008794.pub.2.

    Google Scholar 

  5. Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001;184:101–22.

    Article  CAS  PubMed  Google Scholar 

  6. Maraspin V, Lotrič-Furlan S, Cimperman J, Ružić-Sabljić E, Strle F. Erythema migrans in the immunocompromised host. Wien Klin Wochenschr. 1999;111:923–32.

    CAS  PubMed  Google Scholar 

  7. Fürst B, Glatz M, Kerl H, Müllegger RR. The impact of immunosuppresion on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients. Clin Exp Dermatol. 2006;31:509–14.

    Article  PubMed  Google Scholar 

  8. Maraspin V, Cimperman J, Lotric-Furlan S, Logar M, Ruzić-Sabljić E, Strle F. Erythema migrans in solid-organ transplant recipients. Clin Infect Dis. 2006;42:1751–4.

    Article  PubMed  Google Scholar 

  9. Garcia-Monco JC, Frey HM, Villar BF, Golightly MB, Benach JL. Lyme disease concurrent with human immunodeficiency virus infection. Am J Med. 1989;87:325–8.

    Article  CAS  PubMed  Google Scholar 

  10. Rodríguez M, Chou S, Fisher DC, De Girolami U, Amato AA, Marty FM. Lyme meningoradiculitis and myositis after allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2005;41:e112–4 Epub 2005 Nov 8.

    Article  PubMed  Google Scholar 

  11. Harrer T, Geissdörfer W, Schoerner C, Lang E, Helm G. Seronegative Lyme neuroborreliosis in a patient on treatment for chronic lymphatic leukemia. Infection. 2007;35:110–3.

    Article  CAS  PubMed  Google Scholar 

  12. Bremell D, Säll C, Gisslén M, Hagberg L. Lyme neuroborreliosis in HIV-1 positive men successfully treated with oral doxycycline: a case series and literature review. J Med Case Rep. 2011;19:465. doi:10.1186/1752-1947-5-465.

    Article  Google Scholar 

  13. Cerný R, Machala L, Bojar M, Rozsypal H, Pícha D. Neuroborreliosis in an HIV-1 positive patient. Infection. 2006;34:100–2.

    Article  PubMed  Google Scholar 

  14. Bonnet N, Guis S, Drancourt M, Brouqui P, Berbis P. Borreliosis in a patient treated with anti-TNFα therapy: first case. J Eur Acad Dermatol Venereol. 2011;25:367–8.

    Article  CAS  PubMed  Google Scholar 

  15. van Dop WA, Kersten MJ, de Wever B, Hovious JW. Seronegative Lyme neuroborreliosis in a patient using rituximab. BMJ Case Rep. 2013. doi:10.1136/bcr-2012-007627.

    PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Slovenian Research Agency [Grant P3-0296]. The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Author information

Authors and Affiliations

  1. General Hospital Slovenj Gradec, Slovenj Gradec, Slovenia

    Maja Ivartnik Merkac

  2. Department of Infectious Diseases, University Medical Centre Ljubljana, Japljeva 2, 1525, Ljubljana, Slovenia

    Janez Tomazic & Franc Strle

Authors
  1. Maja Ivartnik Merkac
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janez Tomazic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Franc Strle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Franc Strle.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Merkac, M.I., Tomazic, J. & Strle, F. Lyme neuroborreliosis in a patient treated with TNF-alpha inhibitor. Infection 43, 759–762 (2015). https://doi.org/10.1007/s15010-015-0779-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-015-0779-5

Keywords

Search

Navigation